MORE WAYS TO LISTEN
The upcoming BioPharmaChem Ireland Budget 2026 submission places skills and innovation at its core, emphasising the need for public investment and strategic collaboration across the ecosystem to unlock the sector’s full potential.
In the latest episode of Ibec Responds, Dr. Sinead Keogh, Director of Biopharmachem Ireland and Head of Ibec Sectors, is in conversation with Darrin Morrissey, CEO of NIBRT.
Together, they discuss how the institute is helping to realise Ireland’s ambition in cell and gene therapy. From cutting-edge research and world-class talent development to bold initiatives like the Research Ireland Impact Centre proposal, discover how Ireland is positioning itself as a global leader in therapeutics innovation.
Listen / Previous Episodes
Ep. 102 / Ibec Responds
Navigating the EU Presidency
We are pleased to share a special episode of Ibec Responds. Recorded in our Brussels office, Fergal O’Brien is joined by Pat Ivory and Neil Willoughby to discuss the geopolitical backdrop and key legislative developments leading up to Ireland’s EU Presidency. This episode breaks down the general outlook for the six-month term, offering critical insights into US trade, EU industrial policy, and the strategic priorities outlined in the new Guide.
Ep. 101 / Ibec Responds
Ibec Responds: Securing Ireland’s Competitive Edge on the Global Stage
Ibec CEO Danny McCoy is joined by Ibec President Colin Hunt to reflect on recent high-level global engagements.
Ep. 100 / Ibec Responds
Q4 2025 Ibec Economic Outlook
Gerard Brady, and Mourad Mejdi discuss the major economic events of 2025 including the areas of international trade and the labour market and look forward to 2026, analysing how developments in geopolitics and AI that could shape the economic outlook.